{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:19:03Z","timestamp":1788380343542,"version":"build-2803163510"},"reference-count":34,"publisher":"Frontline Medical Communications, Inc.","issue":"2","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Cutaneous Medicine and Surgery"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.sder.2009.04.008","type":"journal-article","created":{"date-parts":[[2009,7,15]],"date-time":"2009-07-15T09:00:05Z","timestamp":1247648405000},"page":"86-92","source":"Crossref","is-referenced-by-count":100,"title":["Vitiligo Update"],"prefix":"10.12788","volume":"28","author":[{"given":"Rebat M.","family":"Halder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnathan L.","family":"Chappell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5043","reference":[{"key":"10.1016\/j.sder.2009.04.008_bib1","series-title":"Fitzpatrick's Dermatology in General Medicine, Vol 1","article-title":"Vitiligo","author":"Halder","year":"2008"},{"key":"10.1016\/j.sder.2009.04.008_bib2","series-title":"Dermatology and Dermatological Therapy of Pigmented Skin","article-title":"Pigmentary disorders in pigmented skins","author":"Halder","year":"2005"},{"key":"10.1016\/j.sder.2009.04.008_bib3","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.bbrc.2006.05.063","article-title":"Analysis of allelic variants in the catalase gene in patients with the skin depigmenting disorder vitiligo","volume":"345","author":"Gavalas","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.sder.2009.04.008_bib4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1034\/j.1600-0749.2002.00057.x","article-title":"Genetic association of the catalase gene (CAT) with vitiligo susceptibility","volume":"15","author":"Casp","year":"2002","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.sder.2009.04.008_bib5","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0738-081X(97)00126-0","article-title":"Immune mechanisms in vitiligo","volume":"15","author":"Bystryn","year":"1997","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.sder.2009.04.008_bib6","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1523-1747.2001.01408.x","article-title":"Specific cytotoxic T lymphocyte responses against Melan A\/Mart1, tyrosinase and gp100 in vitiligo by the use of major histocompatability complex\/peptide tetramers: The role of cellular immunity in the etiopathogenesis of vitiligo","volume":"117","author":"Palermo","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.sder.2009.04.008_bib7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1034\/j.1600-0749.2003.00023.x","article-title":"Evidence for an autoimmune pathogenesis of vitiligo","volume":"16","author":"Ongenae","year":"2003","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.sder.2009.04.008_bib8","first-page":"146","article-title":"Might there be a link between mannose binding lectin and vitiligo?","volume":"17","author":"Onay","year":"2007","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.sder.2009.04.008_bib9","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1365-4632.2004.02027.x","article-title":"A comparative study of superoxide dismutase, catalase, and glutathione peroxidase activities and nitrate levels in vitiligo patients","volume":"44","author":"Hazneci","year":"2005","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.sder.2009.04.008_bib10","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0923-1811(01)00134-7","article-title":"Levels of neuropeptide Y in the plasma and skin tissue fluids of patients with vitiligo","volume":"27","author":"Tu","year":"2001","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.sder.2009.04.008_bib11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0190-9622(96)90490-9","article-title":"Cytomegalovirus DNA identified in skin biopsy specimens of patients with vitiligo","volume":"35","author":"Grimes","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2009.04.008_bib12","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/01.mcg.0000139052.74801.98","article-title":"Is there any relationship between hep C virus and vitiligo?","volume":"38","author":"Akbayir","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.sder.2009.04.008_bib13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0151-9638(07)91512-4","article-title":"Vitiligo in a black patient associated with HIV infection and repigmentation under antiretroviral therapy","volume":"134","author":"Niamba","year":"2007","journal-title":"Ann Dermatolo Venereol"},{"key":"10.1016\/j.sder.2009.04.008_bib14","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2133.2008.08881.x","article-title":"Guideline for the diagnosis and management of vitiligo","volume":"159","author":"Gawkrodger","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2009.04.008_bib15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/00000372-200404000-00004","article-title":"Inflammatory changes in vitiligo: stage I and II depigmentation","volume":"26","author":"Sharquie","year":"2004","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.sder.2009.04.008_bib16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1348\/000711299160077","article-title":"Coping with the disfiguring effects of vitiligo: A preliminary investigation into the effects of cognitive-behavioural therapy","volume":"72","author":"Papadopoulos","year":"1999","journal-title":"Br J Med Psychol"},{"key":"10.1016\/j.sder.2009.04.008_bib17","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1067\/mjd.2002.120576","article-title":"Vitiligo treated with topical corticosteroids: Children with head and neck involvement respond well","volume":"46","author":"Cockayne","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2009.04.008_bib18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-2133.1974.tb13086.x","article-title":"Treatment of vitiligo with 0.1 percent betamethasone 17-valerate in isopropyl alcohol-a double-blind trial","volume":"91","author":"Kandil","year":"1974","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2009.04.008_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2133.1977.tb05188.x","article-title":"A double-blind trial of 0.05% clobetasol propionate in the treatment of vitiligo","volume":"96","author":"Clayton","year":"1977","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2009.04.008_bib20","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1001\/archderm.142.2.252","article-title":"Lack of efficacy of tacrolimus in the treatment of vitiligo in the absence of UV-B exposure","volume":"142","author":"Ostovari","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2009.04.008_bib21","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/archderm.140.9.1065","article-title":"Topical tacrolimus and the 308-nm excimer laser: A synergistic combination for the treatment of vitiligo","volume":"140","author":"Passeron","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2009.04.008_bib22","first-page":"88","article-title":"Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo","volume":"15","author":"Coskun","year":"2005","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.sder.2009.04.008_bib23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1468-3083.2002.00407.x","article-title":"Treatment of vitiligo by topical calcipotriol","volume":"16","author":"Chiaverini","year":"2002","journal-title":"J Eur Academy Dermatol Vereol"},{"issue":"suppl","key":"10.1016\/j.sder.2009.04.008_bib24","first-page":"30","article-title":"State of the art on the treatment of vitiligo with pseudocatalase","volume":"17","author":"Schallreuter","year":"2003","journal-title":"J Eur Acad Dematol Venereol"},{"key":"10.1016\/j.sder.2009.04.008_bib25","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1046\/j.1365-4362.2002.01463.x","article-title":"Rapid initiation of repigmentation in vitiligo with dead sea climatotherapy in combination with pseudocatalase","volume":"41","author":"Schallreuter","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.sder.2009.04.008_bib26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.jidsp.5640189","article-title":"In vivo and in vitro evidence for hydrogen peroxide accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase","volume":"4","author":"Schallreuter","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.sder.2009.04.008_bib27","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1067\/mjd.2001.113475","article-title":"Oral dexamethasone pulse treatment for vitiligo","volume":"44","author":"Radakovic","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2009.04.008_bib28","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.jaad.2008.03.032","article-title":"Repigmentation of vitiligo during efalizumab","volume":"59","author":"Wakkee","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2009.04.008_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1600-0781.2003.00003.x","article-title":"Photo(chemo) therapy for vitiligo","volume":"19","author":"Roelandts","year":"2003","journal-title":"Photodermatology Phoimmunol Photomed"},{"key":"10.1016\/j.sder.2009.04.008_bib30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1468-3083.2006.01413.x","article-title":"Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo","volume":"20","author":"Parsad","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.sder.2009.04.008_bib31","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1001\/archderm.1997.03890480045006","article-title":"Treatment of vitiligo with UVB radiation vs. topical psoralen plus UVA","volume":"133","author":"Westerhof","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2009.04.008_bib32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2230.2004.01477.x","article-title":"Treatment of vitiligo with the 308 nm excimer laser","volume":"29","author":"Esposito","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.sder.2009.04.008_bib33","series-title":"The Pigmentary System: Physiology and Pathophysiology","first-page":"972","article-title":"Topical treatment of pigmentary disorders","author":"Halder","year":"1998"},{"key":"10.1016\/j.sder.2009.04.008_bib34","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0190-9622(99)70490-1","article-title":"Epidermal grafts for the treatment of stable and progressive vitiligo","volume":"40","author":"Kim","year":"1999","journal-title":"J Am Acad Dermatol"}],"container-title":["Seminars in Cutaneous Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1085562909000315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1085562909000315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/scmsjournal.com\/wp-content\/uploads\/2016\/01\/Vol28_i2-Vitiligo-Update.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T15:06:44Z","timestamp":1616166404000},"score":1,"resource":{"primary":{"URL":"http:\/\/scmsjournal.com\/article\/buy_now\/?id=243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S1085562909000315"],"URL":"https:\/\/doi.org\/10.1016\/j.sder.2009.04.008","relation":{},"ISSN":["1085-5629"],"issn-type":[{"value":"1085-5629","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}